Hyperthyroidism Clinical Trial
Official title:
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
The purpose of this study is to assess if preoperative treatment with Lugol's solution prior to thyroidectomy can reduce the surgical complications hypoparathyroidism and laryngeal nerve palsy
Current practice in Sweden before thyroidectomy due to hyperthyroidism is preoperative treatment with antithyroid drugs (ATD) to all patients with Graves' disease and in cases of toxic nodular goiter with pronounced hyperthyroidism. Iodine solution is administered preoperatively in selected cases of Graves' disease where ATD is intolerable. In the cases where iodine is used it is in the form of extemporaneous prepared iodine potassium iodide solution (Lugol 5%). The dose varies in clinical studies. In American and Swedish guidelines the dose is 5-10 drops 3 times per day for 10 days prior to surgery. American guidelines recommend iodine as preoperative treatment i Graves' disease but this is based on sparse evidence. Iodine as preoperative treatment in toxic nodular goiter has yet not been studied. The purpose of this study is to assess if preoperative treatment with Lugol's solution prior to thyroidectomy due to hyperthyroidism reduce the surgical complications hypoparathyroidism and laryngeal nerve palsy. Before including toxic nodular goiters accepted for surgery, a pilot study will be performed on 20 patients with toxic nodular goiter. They will receive Lugol solution 3 times per day for ten days and thyroid hormone levels will be measured day 0, day 3-4, day 6-7 and after 10 days of Lugol treatment. Heart rate assessed and ThyPRO39 filled out before and after treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05774535 -
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
|
||
| Completed |
NCT02375451 -
Effect of Childhood Radioiodine Therapy on Salivary Function
|
N/A | |
| Recruiting |
NCT00525122 -
Treatment of M.Graves With Radioactive Iodine: Follow-up Study
|
N/A | |
| Completed |
NCT01306916 -
Coexisting Thyroid Disease and Hyperparathyroidism
|
N/A | |
| Completed |
NCT03612908 -
TSHβX1 and D2 THR92ALA in Pregnancy
|
||
| Completed |
NCT03393728 -
Heart Rate Variability and Hyperthyroidism: Evaluation of the Short-term Effects of Propanolol
|
Phase 4 | |
| Completed |
NCT05049551 -
Thyroid Uptake Quantification on a New Generation of Gamma Camera
|
||
| Completed |
NCT02514187 -
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients
|
N/A | |
| Completed |
NCT01727973 -
Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT03064542 -
The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure
|
||
| Completed |
NCT03951532 -
Morbidity and Mortality Associated With the Care Journey in Children and Adolescents With Hyperthyroidism
|
||
| Recruiting |
NCT02772705 -
Comparison of SUV Using SPECT/CT Between Grave's Disease Patients and Normal Humans
|
N/A | |
| Active, not recruiting |
NCT02133040 -
Effects of Hyperthyroidism on Amount and Activity of Brown Adipose Tissue
|
||
| Active, not recruiting |
NCT01105923 -
Study of an Intervention to Improve Problem List Accuracy and Use
|
N/A | |
| Recruiting |
NCT03303053 -
Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism
|
Phase 3 | |
| Enrolling by invitation |
NCT06452823 -
Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
|
||
| Completed |
NCT05385029 -
Fetal and Neonatal Thyroid in Pregnancies With Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS- COV2 ) COVID-19
|
||
| Not yet recruiting |
NCT05252884 -
Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial
|
N/A | |
| Completed |
NCT02499471 -
Brown Adipose Tissue Activity and Thyroid Hormone
|
N/A | |
| Completed |
NCT04825964 -
Exercise Capacity, Physical Activity Levels in Patients With Hyperthyroid
|